Australia

Seeing Machines to unveil 3D Cabin Perception Mapping at CES2026

Pioneering interior sensing technology to advance automotive safety and customer experience CANBERRA, Australia, Jan. 5, 2026 /PRNewswire/ -- Seeing Machines, a global leader in vision-based monitoring technology, today announced it will unveil its next-generation 3D Cabin Perception Mapping sol...

2026-01-05 20:00 8039

Seeing Machines Announces Future Mobility Group, established to deepen integration with Autonomous Vehicle programs

CANBERRA, Australia, Jan. 2, 2026 /PRNewswire/ -- Seeing Machines, a global leader in vision-based monitoring technology, has established a dedicated  Future Mobility Group to support increasing demand from the autonomous driving sector and to advance new commercial opportunities as automated vehi...

2026-01-02 21:00 1566

Co-PSMA abstract accepted for oral presentation at EAU Annual Congress 2026

SYDNEY, Dec. 24, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the acceptance of an ...

2025-12-24 22:02 5178

Kazia Therapeutics Regains Full Nasdaq Listing Compliance

Restoration of Nasdaq compliance follows $50 million institutional financing and reinforces balance-sheet strength SYDNEY, Dec. 22, 2025 /PRNewswire/ -- Kazia Therapeutics Limited ("Kazia" or the "Company") (NASDAQ: KZIA), a clinical-stage oncology company focused on developing innovative therap...

2025-12-22 21:00 7620

BUMA Australia Secures AU$740 Million Multi-Year Contract Extension with Whitehaven at Blackwater Mine Through 2030

* BUMA Australia Pty Ltd ("BUMA Australia"), a wholly owned subsidiary of PT Bukit Makmur Mandiri Utama ("BUMA"), under PT BUMA Internasional Grup Tbk ("BUMA International Group"; IDX: DOID), has secured a multi-year contract extension valued at approximately AU$740 million with Blackwater Oper...

2025-12-22 13:35 4138

Global study targets dengue as disease threatens nearly half the world's population

LISMORE, Australia, Dec. 18, 2025 /PRNewswire/ -- Thousands of dengue forecasting models have been published, but few have been tested in real public-health settings. Now, researchers from the US andAustralia are launching a field evaluation inVietnam to see whether a new early-warning platform c...

2025-12-18 21:01 4782

FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial

Highlights: * FDA has completed their review of the Neurizon NUZ-001 regimen to the HEALEY ALS Platform Trial Master Protocol * This marks the official entry of NUZ-001 as Regimen I in the HEALEY ALS Platform Trial * Next steps include obtaining single IRB approval, site initiations and cl...

2025-12-12 04:49 5030

Solace and NetComm Commercialize World's First Wirelessly Powered, Window-Mounted 5G CPE

MOUNT PEARL, NL and SYDNEY, Dec. 11, 2025 /PRNewswire/ -- Solace Power Inc. ("Solace") and NetComm Wireless ("NetComm") today announced a strategic partnership to co-develop and commercialize the world's first wirelessly powered, window-mounted outdoor 5G customer premises equipment (CPE). The p...

2025-12-11 13:00 2628

Razor Labs Launches DataMind AI™ 4.5, a Major Leap Forward in Predictive Maintenance and Fleet Management for Mining Operations

SYDNEY, Dec. 11, 2025 /PRNewswire/ -- Razor Labs (TASE:RZR) announces the launch ofDataMind AI™ 4.5, a powerful upgrade to its predictive maintenance platform designed formobile fleet management and fixed ass...

2025-12-11 05:00 2428

Kazia Therapeutics Highlights New Clinical and Translational Findings Demonstrating Paxalisib's Ability to Reinvigorate Anti-Tumor Immunity Across Multiple Advanced Breast Cancer Populations including TNBC and HER2+

First patient from TNBC trial demonstrated 76% tumor volume shrinkage with corresponding reductions in circulating tumor cells (CTC) and clusters Reinvigoration of immune system + turning cold tumors hot Preliminary ex-vivo data in HER2+ patients demonstrates immune reinvigoration and reductions...

2025-12-10 21:00 7534

Locksley Announces Oversubscribed A$17 Million Placement Lead by U.S. Investors Funding to Accelerate Execution of Locksley's U.S. Mine to Market Strategy

SAN BERNARDINO, Calif., Dec. 8, 2025 /PRNewswire/ -- Locksley Resources Limited (ASX: LKY/OTCQX: LKYRF/ADR: LKYLY) announced the successful completion of a heavily oversubscribed capital raising, securing firm commitments to raise approximatelyA$17 million via a placement of new shares at A$0.24 ...

2025-12-08 21:30 4298

Yantai offers global bay areas a paradigm of low-carbon transformation

YANTAI, China, Dec. 8, 2025 /PRNewswire/ -- On December 4, the 2025 Shandong Green Low-carbon High-quality Development Conference was held in Yantai,Shandong province. Against the backdrop of the fifth anniversary ofChina's 'dual carbon' goals, Yantai's achievements—as one of the country's first ...

2025-12-08 16:52 2277

X-Design Takes #1 on Product Hunt with AI Agent That Democratizes Branding for Local Businesses

SYDNEY, Dec. 3, 2025 /PRNewswire/ -- X-Design , the AI branding platform built specifically for the brick-and-mortar economy, today announced it has achieved the #1 Product of the Day on Product Hunt. This milestone marks the launch of its newAI Agent

2025-12-04 10:00 3780

X-Design Launched AI Agent: The Always-On Partner That Saves Small Business 70% of Branding time

SYDNEY, Dec. 2, 2025 /PRNewswire/ -- For small business owners, building a beautiful, consistent brand feels out of reach. Creating a logo in one app, designing a menu in another, and making social posts in a third often leads to scattered visuals tha...

2025-12-03 10:10 3472

Kazia Therapeutics Announces Pricing of $50.0 Million Private Placement of Equity Securities

SYDNEY, Dec. 2, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced that it has entered into a securities purchase agreement with certain established institutional and accredited investors for a private placement of equity ...

2025-12-02 22:00 5153

Imugene and JW Therapeutics Announce a Collaboration to Advance onCARlytics and Carteyva® Combination in Solid Tumours

* Imugene and JW Therapeutics (Shanghai) Co., LTD have entered a strategic collaboration to evaluate a novel combination therapy using Imugene's onCARlytics (CF33-CD19) oncolytic virus and JW's CD19 CAR-T cell therapy, Carteyva®, in refractory solid tumors. * The collaboration includes precli...

2025-11-28 13:00 2162

Kazia Therapeutics Achieves Initial iCR (Immune-Complete Response) in Metastatic TNBC and Delivers Q4 Business Update with Breakthroughs Across Breast Cancer, Immuno-Oncology, and GBM Regulatory Strategy

SYDNEY, Nov. 18, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (Nasdaq: KZIA), an oncology-focused drug development company, today announced that a patient with stage IV triple-negative breast cancer (TNBC) treated under an FDA-authorized single-patient expanded access protocol combining paxali...

2025-11-19 05:15 4444

Seeing Machines launches world-first 'attention sharing' feature for enhanced distraction detection capability in commercial fleets

CANBERRA, Australia, Nov. 13, 2025 /PRNewswire/ -- Seeing Machines Limited, the advanced computer vision technology company that designs AI-powered operator monitoring systems to improve transport safety announces the launch of its enhanced distraction detection feature, known as "attention shari...

2025-11-13 16:00 2960

TGE Pursues the Acquisition of the 100th Ritz Carlton Hotel Globally

PARIS, NEW YORK and SINGAPORE, Nov. 10, 2025 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group (NYSE: AMTD; SGX: HKB), AMTD Digital Inc. (NYSE: HKD) and The Generation Essentials Group ("TGE", NYSE: TGE), a subsidiary of AMTD Digital Inc., jointly announce that TGE has entered into ...

2025-11-10 22:25 3110

IR launches new observability-as-a-service platform Prognosis Elevate as hybrid IT complexity surges

Highlights: * Prognosis Elevate is observability-as-a-service for enterprises managing thousands of UC&C endpoints across multiple vendors. * Supports regulated sectors that must balance cloud agility with on-prem and data-residency compliance. * Backed by IR's global 24/7 DevOps and servic...

2025-11-04 10:01 2752
1234567 ... 41